Physician profile
Christine Go
NPI 1356695936
$20,191.57
in general payments reported to CMS, 2019-2025
31 companies · $2,617 in 2025
The $2,617 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,737 · 2022: $4,258 · 2023: $4,498 · 2024: $5,082 · 2025: $2,617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,948 · Food and Beverage: $4,779 · Education: $420 · Travel and Lodging: $49.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,948.00 |
| Food and Beverage | $4,778.64 |
| Education | $420.39 |
| Travel and Lodging | $49.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $5,398.85 | 2021-2025 | Tremfya |
| Ucb, INC. | $3,198.05 | 2021-2025 | Bimzelx, Cimzia |
| Genzyme Corporation | $1,872.33 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,700.76 | 2022-2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $1,251.65 | 2021-2025 | Blu-U, Odomzo |
| Arcutis Biotherapeutics, INC. | $1,072.54 | 2023-2024 | Zoryve |
| Verrica Pharmaceuticals INC. | $1,000.00 | 2024 | Ycanth |
| Leo Pharma INC. | $852.56 | 2021-2023 | Adbry |
| Abbvie INC. | $612.33 | 2021-2025 | |
| Dermavant Sciences, INC. | $481.59 | 2023-2024 | Vtama |
| Incyte Corporation | $479.67 | 2021-2025 | Opzelura |
| Amgen INC. | $434.74 | 2021-2025 | Otezla |
| Regeneron Healthcare Solutions, INC. | $354.28 | 2021-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $346.88 | 2021-2024 | |
| Lilly USA, LLC | $142.50 | 2021-2025 | Taltz, Ebglyss, Olumiant |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prugen, INC. Pharmaceuticals | $140.00 | 2021 | |
| Pfizer INC. | $131.21 | 2021-2025 | |
| Almirall LLC | $122.09 | 2021-2025 | Seysara, Klisyri |
| Journey Medical Corporation | $116.58 | 2024 | |
| Sanofi-Aventis U.S. LLC | $89.69 | 2021 | |
| Lnhc, INC | $74.31 | 2025 | Zelsuvmi |
| Cipher Pharmaceuticals US LLC | $55.93 | 2025 | Spinosad, Natroba |
| Galderma Laboratories, L.P. | $53.32 | 2022-2025 | Nemluvio |
| Krystal Biotech INC | $51.45 | 2025 | Vyjuvek |
| Fresenius Kabi USA, LLC | $44.12 | 2023 | Idacio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.46 | 2024 | Spevigo |
| Blueprint Medicines Corporation | $20.96 | 2023 | Ayvakit |
| Kyowa Kirin, INC. | $19.90 | 2023 | Poteligeo |
| Vyne Pharmaceuticals INC. | $19.37 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.40 | 2024 | Cabtreo |
| Epi Health, LLC | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Go listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.